Overview
Caroline is a General Internist. Her clinical interests are in primary care for vulnerable populations and patients with multiple chronic conditions. Her research interests focus on the role that money plays in medical decision-making. She currently studies financial barriers to care for patients with multiple chronic conditions, the impact of recent price transparency regulations, and the ways that doctors and patients communicate about and make decisions based on out-of-pocket costs.
Current Appointments & Affiliations
Assistant Professor of Medicine
·
2021 - Present
Medicine, General Internal Medicine,
Medicine
Assistant Professor in Population Health Sciences
·
2021 - Present
Population Health Sciences,
Basic Science Departments
Member of the Duke Cancer Institute
·
2022 - Present
Duke Cancer Institute,
Institutes and Centers
Core Faculty Member, Duke-Margolis Institute for Health Policy
·
2024 - Present
Duke-Margolis Institute for Health Policy,
University Institutes and Centers
Recent Publications
Understanding the Causes of Nonadherence to Chronic Medications Among Patients With Cancer and Multimorbidity: A Qualitative Study.
Journal Article J Gen Intern Med · December 9, 2025 BACKGROUND: When patients with multimorbidity (≥ 2 chronic diseases) are diagnosed with cancer, their adherence to non-cancer medications declines. Nonadherence in this patient population has been linked to an increased risk of disease progression, hospita ... Full text Link to item CiteTransforming provider-patient vaccine conversations: a randomised trial on presumptive communication training.
Journal Article BMJ Lead · December 9, 2025 BACKGROUND: Despite the widespread availability of many vaccines and health providers' favourable attitudes towards vaccines, suboptimal immunisation rates persist worldwide. This study investigates the impact of presumptive (opt-out) communication trainin ... Full text Link to item CiteFinancial Toxicity among Survivors of Extremity and Pelvic Sarcoma: A Retrospective Study.
Journal Article Ann Surg Oncol · November 13, 2025 BACKGROUND: Financial toxicity in oncology, defined as the economic burden and psychosocial distress of cancer care, has been associated with poor clinical outcomes. Despite high projected treatment costs, data on financial toxicity in patients with sarcom ... Full text Link to item CiteRecent Grants
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
ResearchPrincipal Investigator · Awarded by National Institute on Aging · 2023 - 2027Heterogeneity in Medication Therapy Management Used to Reduce Potentially Inappropriate Medication Use
ResearchCo Investigator · Awarded by University of Massachusetts Medical School · 2024 - 2025Development of a Financial Toxicity Measurement Tool for Patients with Multimorbidity
ResearchSignificant Contributor · Awarded by University of Massachusetts Medical School · 2023 - 2024View All Grants
Education, Training & Certifications
University of Pennsylvania, School of Medicine ·
2015
M.D.